Minimally invasive burn reconstruction with subcutaneous scar contracture release.

BACKGROUND: Scar contracture bands after burns are frequent problems that cause discomfort and physical limitation. This study investigates the efficacy of a minimally invasive contracture band release technique (MICBR) inspired by closed platysmotomy. METHODS: Patients with burn scars treated with MICBR in our center were included retrospectively. Our routine scar and contracture treatments (non-invasive and invasive) were utilized prior to undergoing MICBR. Range of motion (ROM) and Vancouver Scar Scale was measured before and after the procedure when feasible. RESULTS: Forty-five patients were included, with 97 total contracture sites treated all over the body. An average of 1.6 sites were treated per patient, with a maximum of six. Patients age was 6-68 years; total burn surface area ranged from 0.5% to 85%. 24% were performed under local anesthesia. 84% were in originally skin grafted areas. We found significant improvements in ROM and VSS. 84% of patients surveyed were "satisfied" or "very satisfied". 95% reported improved mobility. No significant adverse events occurred. CONCLUSION: This MICBR technique is a versatile, safe, and well-tolerated adjunct procedure that can help patients regain mobility after a burn injury.

Epidermal-cell-based therapy as an adjunct to healing second degree burns-A randomized controlled pilot study.

BACKGROUND: Healing of partial-thickness (2a and 2b) burns is notoriously unpredictable as far as healing time, scarring and (hypo)pigmentation is concerned. Epidermal blister grafting is an autologous grafting technique involving transfer of epidermal islands without dermal elements. Cellutome™ is an FDA-acknowledged epidermal harvesting device. This proof-of-concept study evaluates whether blister grafting of partial-thickness burns results in improved healing compared to standard acellular treatment. METHODS: This is a randomized controlled trial with 8 patients in which each patient received both treatments randomized to different burn sites. Healing was assessed at regular intervals. Twelve months after treatment, outcomes were measured with the Vancouver Scar Scale (VSS), Patient and Observer Scar Assessment Scale (POSAS), photography, spectrometry, Semmes-Weinstein Filaments, cutometry and high-resolution ultrasound. RESULTS: Areas treated with epidermal blister grafting healed slightly faster than acellular treatment. Epidermal treatment yielded healing with less erythema, closer to that of surrounding normal skin (p = 0.0404). Donor sites were not visible and not measurably different than normal skin. CONCLUSIONS: Results favor cellular over acellular technique for the treatment of partial-thickness (2a and 2b) burns. Significant improvement in erythema implies a higher quality healing process. Further studies should look primarily at larger areas of treatment, and larger sample size.

A 6-Year Experience of Laser Treatments for Burn Scars in a Regional Burn Center-Safety, Efficacy, and Quality Improvement.

Laser treatments have long been used as a treatment method for burn scars. Since 2012, more than 1800 laser treatments were performed at Lehigh Valley Health Network Burn Center, far exceeding any previous cohort in studies exploring laser treatments for burn scars. Although previous research has looked at improving scar appearance and physiology with laser treatments, very few have focused on safety. The purpose of the study was to determine whether laser treatments are a safe treatment option for burn scars. Four hundred and fourteen patients who had undergone at least one laser treatment in the outpatient burn center since 2012 were analyzed. Electronic medical records (EPIC) were reviewed. The data were entered in REDCap and later exported to Microsoft Excel and R Studio for statistical analysis. Most of the complications found were related to the moderate sedation during the procedures and were mild, ie, nausea. The most common adverse effect was prolonged recovery time, which can affect practice flow. The overall postoperative complication rate for laser treatments with and without moderate sedation was minimal at 2.2% and 1.4%, respectively. Pain during and after the procedure averaged 3.9 and 1.7, respectively, on a 1 to 10 scale. The Vancouver Scar Scale showed modest improvement in scar appearance over time with an average improvement of 1.4. The high variability of the Vancouver Scar Scale observed in this series underlines its lack of sensitivity. The study results show that laser treatments for burn scars in the outpatient setting generally are safe for patients in need of burn scar intervention. Some practice flow adjustments need to be taken into consideration when offering these procedures in an outpatient setting.

Assessment of Hair Density and Sub-epidermal Tissue Thickness in Burn Scars Using High-Definition Ultrasound Imaging.

Burn scars show significant differences in structure, pigment, and hair density/sparsity from unburned skin, yet no formal documentation of these changes can be found in the literature. Evaluation of these differences is essential to assessing future intervention outcomes. The study was a prospective controlled clinical trial. Included were 19 adult burn survivors (18-63 years old, average age 47; 15 male, 4 female, 14 Caucasian, 2 African American, 1 Hispanic; 11 flame burns, 5 scald burns, 2 grease burns and 1 electrical burn, 2%-60% TBSA) with conspicuous, mature scars. All study subjects had either skin-grafted or nongrafted scars, as well as healthy skin in the same body area, to control for intraindividual variability. All scars were at least 9 months old and at a minimum 2 × 2 cm2 in size. On each individual, at least one nongrafted scar or one grafted scar and healthy skin was imaged with a high-definition ultrasound device (Longport, Inc., Glen Mills, PA, 35MHz probe, 1500 m/s). Vancouver scar scale was assessed. Although scarred skin had significantly fewer follicles than healthy skin in both grafted (P < .0001) and un-grafted sites (P = .0090), there were even significantly fewer follicles in grafted scars than un-grafted scars (P = .0095). In thickness of the sub-epidermal layer, there was no difference between grafted and un-grafted scars (P = .1900). Both kinds of scars had a significantly thicker sub-epidermal layer than healthy skin (P = .0010). Vancouver scar scale was 7.4 for grafted and 4.6 for nongrafted scars with grafted flame burn scars ranging higher than all others (5-11). There was no discomfort during the imaging, and no adverse events occurred during the study period. Our study demonstrates two clear morphologic differences between scars and healthy skin: thickness of the sub-epidermal layer and hair follicle density. Grafted burn scars were shown to contain fewer hair follicles than un-grafted scars.

Prospective Evaluation of Fractional CO2 Laser Treatment of Mature Burn Scars.

The authors conducted a prospective study of fractional CO2 laser treatment of mature burn scars, comparing objective and subjective scar measurements evaluating at least one treatment and one control scar on the same patient pre- and post treatments. After institutional review board approval, burn survivors with mature blatant burn scars were invited to enter the study. A series of three fractional CO2 laser treatments was performed in an office setting, using topical anesthetic cream, at 40 to 90 mJ, 100 to 150 spots per cm(2). Subjective and objective measurements of scar physiology and appearance were performed before and at least 1 month after the treatment series on both the treated and the control scar. A total of 80 scars, 48 treatment and 32 control scars, were included in the study. Treatment pain score averaged at 4.7/10 during and at 2.4/10 5 minutes after the treatment. All treated scars showed improvement. Objectively measured thickness, sensation, erythema, and pigmentation improved significantly in the treated scars (P = .001, .001, .004, and .001). Elasticity improved, but without statistical significance. Vancouver scar scale assessments by an independent observer improved from 8 to 6; patient self-reported pain and pruritus remained unchanged in both groups. Fractional CO2 laser treatment is a promising entity in the treatment of burn scars. Our study results show significant differences in objective measurements between the treated scars and the untreated control scars over the same time period. In scar treatment studies, the patient/observer and Vancouver scar scales may not be sensitive enough to detect outcome differences.

Effect of subcutaneous epinephrine/saline/local anesthetic versus saline-only injection on split-thickness skin graft donor site perfusion, healing, and pain.

The technique for split-thickness skin graft harvest varies among surgeons. Even though there is scientific evidence that the subcutaneous injection of modified tumescent solution reduces blood loss during burn surgery, the technique has not been unanimously adapted because of, in part, fear of healing retardation. This study prospectively examines the effect of tumescent injection on donor site perfusion, healing, and pain. Ten burn patients in need of grafting with a need for two distinctly different donor sites were included. During the grafting procedure, the two donor areas were randomly assigned to receive either modified tumescent solution or warm sterile saline solution subcutaneously before skin graft harvest with a dermatome. Perfusion, pain, pruritus, and donor site healing were measured, and a follow-up evaluation on scar quality was performed. Baseline perfusion on day 1 was significantly less in the donor site injected with modified tumescent solution (62.26 vs 95.71 perfusion units; P = .031), whereas the response to heat was similar in both sites. The physiologic response to injury (hyperemia) on days 2 and 3 was not suppressed in the modified tumescent group. Pain reported on day 1 was 2.38/10 in the tumescent site and 3.38/10 in the saline site (P = .21). On all other days, measurements showed no difference between the two sites. Donor sites healed in an average of 16.1 days with modified tumescent solution and in 16.4 days with saline. Late follow-up showed no difference in scar quality. The subcutaneous injection of modified tumescent solution before split-thickness donor site harvest has no adverse effect on donor site perfusion past day 1 or donor site healing. The addition of a local anesthetic may decrease pain for 24 hours postoperatively, but the difference in this study group was not significant. This technique should be universally recommended.

Exploration of nonsurgical scar modification options: can the irregular surface of matured mesh graft scars be smoothed with microdermabrasion?

The purpose of this study was to determine, in principle, whether microdermabrasion can alter waffle-pattern (meshed split-thickness skin graft) burn scars after scar maturation. Matured waffle-pattern mesh-graft scars were treated with multiple microdermabrasion sessions over the course of a year (maximum 20). Before and after treatment, the treated scars and the control scar on the same patient were assessed with subjective and objective scar assessment tools (scar scales, cutometer [elasticity], laser Doppler flowmeter [vascularity], Semmes-Weinstein filaments [sensation], and high-resolution ultrasound [thickness]). The treatment resulted in continuous improvement of some physiologic skin functions like perfusion response (feedback), thickness, and elasticity when compared with nontreated scar, although no statistical significance was reached. Both Vancouver scar scale and patient assessment scales showed significant improvement. The study showed that even mature waffle pattern scars can be modified by minimally invasive interventions. Larger study groups and more economic treatment modalities need to be studied in the future.

Do hybrid simulator-generated metrics correlate with content-valid outcome measures?

BACKGROUND: Hybrid simulators provide objective metrics for laparoscopic task performance. This study aimed to evaluate the correlation between hybrid simulator-generated metrics and content-valid outcome measures. METHODS: Residents underwent training with a previously validated 5-task simulation model (5-TSM). The resident tasks included vessel clipping and dividing, lesion excision, loop appendectomy, mesh placement with tacks, and suture perforation with intracorporeal knot tying. After training, the residents were tested using the open module of a hybrid simulator (ProMIS) with previously validated passing scores. Content validity was defined as the extent to which outcome measures departed from clinical reality. Content-valid outcome measures (accuracy error, knot slippage, leak, operating time, tissue damage) were evaluated by two blinded raters. The hybrid simulator-generated metrics were path length and smoothness of movements. Values are given as means (standard deviation is not shown). RESULTS: Over 23 months, 20 residents underwent training with 5-TSM. Respectively, for tasks 1 to 5, the path length was 3,895, 3,472, 4,620, 2,408, and 9,089 mm; the smoothness (jerk) was 346, 455, 549, 264, and 910 cm/sec3; the accuracy error was 0.45, 2.20, 0.55, 0.87, and 0.20 mm; and the knot slippage was 5%. There were no leaks. The operating time, respectively, was 54, 61, 135, 43, and 130 s, and the tissue damage was 0, 0.28, 0, 0.8, and 0 mm. The interrater reliability was more than 0.80 for all the outcome measures except accuracy error (k=0.52). There was correlation between path length and operating time (Spearman rho, 0.537-0.709; p<0.05) for all the tasks. There was no correlation between path length and accuracy error, knot slippage, leak, and tissue damage. No correlation was found between smoothness and any of the outcome measures for any of the tasks except operating time (Spearman rho, 0.762-0.958; p<0.05). CONCLUSIONS: Although an expected strong correlation was observed between hybrid simulator-generated metrics and operating time, this study showed no correlation between simulator-generated metrics and other content-valid outcome measures.